• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤内和粪便微生物群揭示了与胃癌发生相关的微生物标志物。

Intratumoral and fecal microbiota reveals microbial markers associated with gastric carcinogenesis.

作者信息

Wang Yiwen, Wang Yue, Han Wenjie, Han Mengzhen, Liu Xiaolin, Dai Jianying, Dong Yuesheng, Sun Tao, Xu Junnan

机构信息

Department of Breast Medicine 1, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, China.

Department of Pharmacology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, China.

出版信息

Front Cell Infect Microbiol. 2024 Sep 17;14:1397466. doi: 10.3389/fcimb.2024.1397466. eCollection 2024.

DOI:10.3389/fcimb.2024.1397466
PMID:39355268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11442432/
Abstract

BACKGROUND

The relationship between dysbiosis of the gastrointestinal microbiota and gastric cancer (GC) has been extensively studied. However, microbiota alterations in GC patients vary widely across studies, and reproducible diagnostic biomarkers for early GC are still lacking in multiple populations. Thus, this study aimed to characterize the gastrointestinal microbial communities involved in gastric carcinogenesis through a meta-analysis of multiple published and open datasets.

METHODS

We analyzed 16S rRNA sequencing data from 1,642 gastric biopsy samples and 394 stool samples across 11 independent studies. VSEARCH, QIIME and R packages such as vegan, phyloseq, cooccur, and random forest were used for data processing and analysis. PICRUSt software was employed to predict functions.

RESULTS

The α-diversity results indicated significant differences in the intratumoral microbiota of cancer patients compared to non-cancer patients, while no significant differences were observed in the fecal microbiota. Network analysis showed that the positive correlation with GC-enriched bacteria increased, and the positive correlation with GC-depleted bacteria decreased compared to healthy individuals. Functional analyses indicated that pathways related to carbohydrate metabolism were significantly enriched in GC, while biosynthesis of unsaturated fatty acids was diminished. Additionally, we investigated non- commensals, which are crucial in both -negative and -positive GC. Random forest models, constructed using specific taxa associated with GC identified from the LEfSe analysis, revealed that the combination of Lactobacillus and Streptococcus included alone could effectively discriminate between GC patients and healthy individuals in fecal samples (area under the curve (AUC) = 0.7949). This finding was also validated in an independent cohort (AUC = 0.7712).

CONCLUSIONS

This study examined the intratumoral and fecal microbiota of GC patients from a dual microecological perspective and identified and as intratumoral and intestinal-specific co-differential bacteria. Furthermore, it confirmed the validity of the combination of and as GC-specific microbial markers across multiple populations, which may aid in the early non-invasive diagnosis of GC.

摘要

背景

胃肠道微生物群失调与胃癌(GC)之间的关系已得到广泛研究。然而,不同研究中GC患者的微生物群变化差异很大,且在多人群中仍缺乏可重复的早期GC诊断生物标志物。因此,本研究旨在通过对多个已发表和公开数据集的荟萃分析,来描述参与胃癌发生的胃肠道微生物群落特征。

方法

我们分析了来自11项独立研究的1642份胃活检样本和394份粪便样本的16S rRNA测序数据。使用VSEARCH、QIIME以及vegan、phyloseq、cooccur和random forest等R包进行数据处理和分析。采用PICRUSt软件预测功能。

结果

α多样性结果表明,与非癌症患者相比,癌症患者肿瘤内微生物群存在显著差异,而粪便微生物群未观察到显著差异。网络分析表明,与健康个体相比,与GC富集菌的正相关性增加,与GC耗竭菌的正相关性降低。功能分析表明,与碳水化合物代谢相关的途径在GC中显著富集,而不饱和脂肪酸的生物合成减少。此外,我们研究了在阴性和阳性GC中均起关键作用的非共生菌。使用从LEfSe分析中确定的与GC相关的特定分类群构建的随机森林模型显示,单独的乳酸杆菌和链球菌组合能够有效区分粪便样本中的GC患者和健康个体(曲线下面积(AUC)=0.7949)。这一发现也在一个独立队列中得到验证(AUC = 0.7712)。

结论

本研究从双重微生态角度研究了GC患者的肿瘤内和粪便微生物群,鉴定出[具体细菌名称未给出]作为肿瘤内和肠道特异性共差异细菌。此外,它证实了[具体细菌名称未给出]组合作为多人群GC特异性微生物标志物的有效性,这可能有助于GC的早期非侵入性诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/d5d5c7186c8f/fcimb-14-1397466-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/9b2938117842/fcimb-14-1397466-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/08d8b74151ce/fcimb-14-1397466-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/ab92c163bfd4/fcimb-14-1397466-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/0b88496ed1e6/fcimb-14-1397466-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/58b4b2f4cc80/fcimb-14-1397466-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/d5d5c7186c8f/fcimb-14-1397466-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/9b2938117842/fcimb-14-1397466-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/08d8b74151ce/fcimb-14-1397466-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/ab92c163bfd4/fcimb-14-1397466-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/0b88496ed1e6/fcimb-14-1397466-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/58b4b2f4cc80/fcimb-14-1397466-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11442432/d5d5c7186c8f/fcimb-14-1397466-g006.jpg

相似文献

1
Intratumoral and fecal microbiota reveals microbial markers associated with gastric carcinogenesis.肿瘤内和粪便微生物群揭示了与胃癌发生相关的微生物标志物。
Front Cell Infect Microbiol. 2024 Sep 17;14:1397466. doi: 10.3389/fcimb.2024.1397466. eCollection 2024.
2
Mucosal microbiome dysbiosis in gastric carcinogenesis.胃肿瘤发生中的黏膜微生物组失调。
Gut. 2018 Jun;67(6):1024-1032. doi: 10.1136/gutjnl-2017-314281. Epub 2017 Aug 1.
3
Analysis of gastric microbiome reveals three distinctive microbial communities associated with the occurrence of gastric cancer.胃微生物组分析揭示了与胃癌发生相关的三种独特微生物群落。
BMC Microbiol. 2022 Jul 23;22(1):184. doi: 10.1186/s12866-022-02594-y.
4
Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.联合应用无创预测方法和新型生物标志物检测胃癌和结直肠癌患者的口腔和粪便微生物群。
Front Cell Infect Microbiol. 2022 May 19;12:830684. doi: 10.3389/fcimb.2022.830684. eCollection 2022.
5
Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis.黏膜微生物组学荟萃分析揭示了胃肿瘤发生过程中的普遍微生物特征和失调。
Oncogene. 2022 Jul;41(28):3599-3610. doi: 10.1038/s41388-022-02377-9. Epub 2022 Jun 9.
6
Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis.胃黏膜和胃液微生物组在胃癌发生过程中的趋同失调。
Gastric Cancer. 2022 Sep;25(5):837-849. doi: 10.1007/s10120-022-01302-z. Epub 2022 Jun 4.
7
A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients.胃癌患者肿瘤相关与非肿瘤相关胃微生物组的比较。
Dig Dis Sci. 2021 May;66(5):1673-1682. doi: 10.1007/s10620-020-06415-y. Epub 2020 Jun 26.
8
Effect of on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer.在胃癌高发区临朐基于人群的研究:对胃肠道微生物群的影响。
Gut. 2020 Sep;69(9):1598-1607. doi: 10.1136/gutjnl-2019-319696. Epub 2019 Dec 19.
9
Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer.276 例胃癌患者不同胃微生境胃黏膜微生物群的改变。
EBioMedicine. 2019 Feb;40:336-348. doi: 10.1016/j.ebiom.2018.12.034. Epub 2018 Dec 21.
10
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.胃微生物群落分析揭示了一种与癌症相关的失调微生物群。
Gut. 2018 Feb;67(2):226-236. doi: 10.1136/gutjnl-2017-314205. Epub 2017 Nov 4.

引用本文的文献

1
Gastrointestinal microbiota in treatment of gastric precancerous lesions and gastric cancer by Western and traditional Chinese medicine.胃肠道微生物群在中西医治疗胃癌前病变和胃癌中的应用
World J Clin Oncol. 2025 Aug 24;16(8):107660. doi: 10.5306/wjco.v16.i8.107660.
2
Gut microbiota in gastric cancer: from pathogenesis to precision medicine.胃癌中的肠道微生物群:从发病机制到精准医学
Front Microbiol. 2025 Jul 30;16:1606924. doi: 10.3389/fmicb.2025.1606924. eCollection 2025.
3
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy.

本文引用的文献

1
The role of microbiomes in gastrointestinal cancers: new insights.微生物群落在胃肠道癌症中的作用:新见解
Front Oncol. 2024 Feb 1;13:1344328. doi: 10.3389/fonc.2023.1344328. eCollection 2023.
2
Inhibition of ferroptosis by POLE2 in gastric cancer cells involves the activation of NRF2/GPX4 pathway.胃癌细胞中 POLE2 通过激活 NRF2/GPX4 通路抑制铁死亡。
J Cell Mol Med. 2024 Jan;28(1):e17983. doi: 10.1111/jcmm.17983. Epub 2023 Dec 9.
3
The role of microbiota in the development and treatment of gastric cancer.微生物群在胃癌发生发展及治疗中的作用。
利用肿瘤内微生物群:免疫微环境与免疫治疗的新视野
J Transl Med. 2025 Aug 12;23(1):897. doi: 10.1186/s12967-025-06916-2.
4
Dissecting the Genetic Correlations and Causal Effects of Gut Microbiota on Pan-Cancer Phenotype: Driven by Common Dietary Preferences.剖析肠道微生物群对泛癌表型的遗传相关性和因果效应:受常见饮食偏好驱动。
Food Sci Nutr. 2025 Jul 28;13(8):e70708. doi: 10.1002/fsn3.70708. eCollection 2025 Aug.
5
Sustainable Innovations in Food Microbiology: Fermentation, Biocontrol, and Functional Foods.食品微生物学中的可持续创新:发酵、生物防治与功能食品。
Foods. 2025 Jun 30;14(13):2320. doi: 10.3390/foods14132320.
6
The Role of Microbiota in Upper Gastrointestinal Cancers.微生物群在上消化道癌症中的作用。
Cancers (Basel). 2025 May 21;17(10):1719. doi: 10.3390/cancers17101719.
7
Revealing gut microbiota biomarkers associated with melanoma immunotherapy response and key bacteria-fungi interaction relationships: evidence from metagenomics, machine learning, and SHAP methodology.揭示与黑色素瘤免疫治疗反应相关的肠道微生物群生物标志物以及关键的细菌-真菌相互作用关系:来自宏基因组学、机器学习和SHAP方法的证据。
Front Immunol. 2025 Mar 18;16:1539653. doi: 10.3389/fimmu.2025.1539653. eCollection 2025.
8
Nanomaterials in gastric cancer: pioneering precision medicine for diagnosis, therapy, and prevention.胃癌中的纳米材料:用于诊断、治疗和预防的开创性精准医学。
Med Oncol. 2025 Mar 6;42(4):93. doi: 10.1007/s12032-025-02650-3.
9
Advances in 16S rRNA-Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis.基于16S rRNA的胃癌诊断与预后微生物生物标志物研究进展
Microb Biotechnol. 2025 Feb;18(2):e70115. doi: 10.1111/1751-7915.70115.
Front Oncol. 2023 Sep 29;13:1224669. doi: 10.3389/fonc.2023.1224669. eCollection 2023.
4
Identification of microbial markers associated with lung cancer based on multi-cohort 16 s rRNA analyses: A systematic review and meta-analysis.基于多队列 16S rRNA 分析鉴定与肺癌相关的微生物标志物:系统评价和荟萃分析。
Cancer Med. 2023 Sep;12(18):19301-19319. doi: 10.1002/cam4.6503. Epub 2023 Sep 7.
5
Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer.可溶性 HLA-G(sHLA-G)的测量可能作为一种早期诊断生物标志物和胃癌筛查试验有用。
Sci Rep. 2023 Aug 12;13(1):13119. doi: 10.1038/s41598-023-40132-6.
6
Endoscopic screening and surveillance for gastric cancer: challenges and opportunities.胃癌的内镜筛查与监测:挑战与机遇
Fac Rev. 2023 Jul 13;12:17. doi: 10.12703/r/12-17. eCollection 2023.
7
Updates on global epidemiology, risk and prognostic factors of gastric cancer.全球胃癌流行病学、风险和预后因素的最新研究进展。
World J Gastroenterol. 2023 Apr 28;29(16):2452-2468. doi: 10.3748/wjg.v29.i16.2452.
8
Meta-analysis reveals mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression.荟萃分析揭示了胃癌进展过程中胃微生物组的相互排他性和可重复性改变。
Gut Microbes. 2023 Jan-Dec;15(1):2197835. doi: 10.1080/19490976.2023.2197835.
9
Alterations in bacterial community dynamics from noncancerous to Gastric cancer.从非癌状态到胃癌过程中细菌群落动态的改变。
Front Microbiol. 2023 Mar 9;14:1138928. doi: 10.3389/fmicb.2023.1138928. eCollection 2023.
10
Updated epidemiology of gastrointestinal cancers in East Asia.东亚地区胃肠道癌症的最新流行病学情况。
Nat Rev Gastroenterol Hepatol. 2023 May;20(5):271-287. doi: 10.1038/s41575-022-00726-3. Epub 2023 Jan 11.